A new feature on the cholesterol-lowering landscape
- 1 December 2001
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 7 (12) , 1282-1284
- https://doi.org/10.1038/nm1201-1282
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- SCAP ligands are potent new lipid-lowering drugsNature Medicine, 2001
- Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studiesClinical Therapeutics, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Regulation of gene expression by SREBP and SCAPBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβGenes & Development, 2000
- A proteolytic pathway that controls the cholesterol content of membranes, cells, and bloodProceedings of the National Academy of Sciences, 1999
- Blunted feedback suppression of SREBP processing by dietary cholesterol in transgenic mice expressing sterol-resistant SCAP(D443N).Journal of Clinical Investigation, 1998
- An MTP Inhibitor That Normalizes Atherogenic Lipoprotein Levels in WHHL RabbitsScience, 1998
- Statin trials and goals of cholesterol-lowering therapy.Circulation, 1998
- Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver.Proceedings of the National Academy of Sciences, 1995